Apoptosis assays further revealed that PRMT1 knockdown, especially with CBP treatment, significantly increased apoptosis in HNSCC cells, which was partially reversed by IGF2BP2 overexpression (Figure 4D). The gene discussed is IGF2BP2; the disease is head and neck squamous cell carcinoma.